Used primarily in the treatment of hypertension, this compound acts as a selective imidazoline I1 receptor agonist, helping to reduce sympathetic nervous system activity. This leads to a decrease in peripheral vascular resistance and lower blood pressure. Due to its central mechanism of action, it offers antihypertensive effects with a lower incidence of dry cough compared to ACE inhibitors. It is often prescribed as a once-daily oral medication for long-term management of high blood pressure. Some studies suggest potential benefits in patients with metabolic syndrome, as it may have neutral or favorable effects on glucose and lipid metabolism.